Thrive Earlier Detection Corp

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

From the website:Patients at Mass General have access to a vast network of physicians, nearly all of whom are Harvard Medical School faculty and many of whom are leaders within their fields.

Immigration Parentage Testing, based in Boston, MA, specializes in providing DNA testing services for United States immigration purposes. Their services are available worldwide, allowing clients to easily access DNA tests for immigration applications. Clients are encouraged to familiarize themselves with the testing protocol by visiting the company's website before scheduling an examination. Immigration Parentage Testing also offers special payment plans to accommodate their clients' financial needs. Generated from their available business information